Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Novo Holdings A/S Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 SC 13D/A Novo Holdings A/S reports a 12% stake in IO Biotech, Inc.
08/03/2023 SC 13D/A Novo Holdings A/S reports a 4.4% stake in Cyteir Therapeutics, Inc.
07/26/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/28/2023 SC 13D/A Novo Holdings A/S reports a 9.6% stake in Edgewise Therapeutics, Inc.
05/15/2023 SC 13D/A Novo Holdings A/S reports a 10.2% stake in Reneo Pharmaceuticals, Inc.
02/24/2023 SC 13D/A Novo Holdings A/S reports a 11.7% stake in LAVA Therapeutics N.V.
01/04/2023 SC 13D/A Novo Holdings A/S reports a 0% stake in Bolt Biotherapeutics, Inc.
12/28/2022 SC 13D/A Novo Holdings A/S reports a 6.7% stake in Bolt Biotherapeutics, Inc.
10/24/2022 SC 13D/A Novo Holdings A/S reports a 4.6% stake in Milestone Pharmaceuticals Inc.
10/03/2022 SC 13D/A Novo Holdings A/S reports a 12.9% stake in LAVA Therapeutics N.V.
09/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/30/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/26/2022 SC 13D/A Novo Holdings A/S reports a 7% stake in Milestone Pharmaceuticals Inc.
09/16/2022 SC 13D/A Novo Holdings A/S reports a 9.6% stake in Edgewise Therapeutics, Inc.
08/18/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/02/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/22/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/15/2022 SC 13D/A Novo Holdings A/S reports a 9.8% stake in Bolt Biotherapeutics, Inc.
06/03/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/03/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/26/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/02/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/08/2022 SC 13D/A Novo Holdings A/S reports a 6.9% stake in Mirum Pharmaceuticals, Inc.
02/22/2022 SC 13D/A Novo Holdings A/S reports a 4.9% stake in Morphic Holding, Inc.
01/31/2022 SC 13D/A Novo Holdings A/S reports a 4.9% stake in Aligos Therapeutics, Inc.
01/27/2022 SC 13D/A Novo Holdings A/S reports a 14% stake in Reneo Pharmaceuticals, Inc.
12/20/2021 SC 13D/A Novo Holdings A/S reports a 13.6% stake in Cyteir Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy